Stockreport

Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump [CNBC]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Sales were up 2% at constant exchange rates, led by stronger demand for Roche's newer medicines and diagnostics, the company said. Excluding Covid-19 products, sales we [Read more]